A new clinical trial of a drug which could help slow down the progression of early Alzheimer’s disease is underway at Foss Park Hospital in York.
Morning Overview on MSN
Study links reduced visual sensitivity to dementia risk up to 12 years early
Researchers at Loughborough University have found that reduced visual processing speed can flag dementia risk as many as 12 ...
Denali Therapeutics said Takeda Pharmaceuticals terminated the companies' agreement to co-develop and commercialize a dementia drug. Denali would regain full ownership of DNL593, an investigational ...
Never has such a wealth of information been at your fingertips to explain your symptoms or summon deepfakes to sell you on ...
Scientists are beginning to understand that the same diet may not work the same way for everyone. A new study from Karolinska ...
A large US claims-based study found that adults aged 65 and older who received a high-dose flu vaccine had a lower observed ...
A multisite study led by UC San Diego and UC Davis will examine changes in brain imaging, blood biomarkers and cognition over ...
Sharing that “dementia is a disease of moments," a Kenyan researcher teaches families how to better care for their loved ones ...
The panel of six metabolites reflects early metabolic disruption along the gut-brain axis, he noted. "These results highlight ...
When most people think of dementia, a specific image comes to mind. However, there are several subtypes of the disease that ...
Over the past few years, health experts have encouraged people to limit their meat consumption thanks to growing data linking ...
Lewy body dementia is the second-most-common dementia, but it is underrecognized. Recognizing its distinct symptoms can help ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results